Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · October 15, 2022

Association of Anticoagulation With Mortality, Healthcare Utilization, and Quality of Life in Patients With Pulmonary Arterial Hypertension

The Journal of Heart and Lung Transplantation


Additional Info

The Journal of Heart and Lung Transplantation
Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR)
J. Heart Lung Transplant 2022 Aug 28;[EPub Ahead of Print], JD Garry, NA Kolaitis, R Kronmal, T Thenappan, A Hemnes, D Grinnan, T Bull, MM Chakinala, E Horn, MA Simon, T De Marco

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading